Fatigue management in patients with IBD: A randomised controlled trial

Gut

Volumn 63, Issue 6, 2014, Pages 911-918

  Vogelaar, Lauran ^a   Van't Spijker, Adriaan ^a   Timman, Reinier ^a   Van Tilburg, Antonie J P ^b   Bac, Dirk Jan ^b   Vogelaar, Ton ^a   Kuipers, Ernst J ^a   Van Busschbach, Jan J V ^a   Van Der Woude, Christien J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Department of Psychology and Psychotherapy Erasmus MC ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN;

ADULT; ADVERSE OUTCOME; ANXIETY DISORDER; ARTICLE; CHECKLIST INDIVIDUAL STRENGTH FATIGUE SCORE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG USE; FATIGUE; FEMALE; FOLLOW UP; HUMAN; INFLAMMATORY BOWEL DISEASE; LABORATORY TEST; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; PSYCHOTHERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SLEEP QUALITY; SOLUTION FOCUSED THERAPY; TREATMENT RESPONSE;

IBD CLINICAL; INFLAMMATORY BOWEL DISEASE;

ADULT; ANXIETY; C-REACTIVE PROTEIN; DEPRESSION; FATIGUE; FEMALE; GASTROINTESTINAL AGENTS; HEMOGLOBINS; HUMANS; INFLAMMATORY BOWEL DISEASES; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY, GROUP; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SLEEP;

EID: 84899754175     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2013-305191     Document Type: Article

References (69)

1. Minderhoud IM, Oldenburg B, van Dam PS, et al. High prevalence of fatigue in quiescent inflammatory bowel disease is not related to adrenocortical insufficiency. Am J Gastroenterol 2003;98:1088-93. (Pubitemid 36733771)
2. Jelsness-Jorgensen LP, Bernklev T, Henriksen M, et al. Chronic fatigue is associated with impaired health-related quality of life in inflammatory bowel disease. Aliment Pharmacol Ther 2011;33:106-14.
3. Romberg-Camps MJ, Bol Y, Dagnelie PC, et al . Fatigue and health-related quality of life in inflammatory bowel disease: results from a population-based study in the Netherlands: the IBD-South Limburg cohort. Inflamm Bowel Dis 2010;16:2137-47.
4. Gasche C, Lomer MC, Cavill I, et al. Iron, anaemia, and inflammatory bowel diseases. Gut 2004;53:1190-7. (Pubitemid 38961976)
5. Graff LA, Vincent N, Walker JR, et al. A population-based study of fatigue and sleep difficulties in inflammatory bowel disease. Inflamm Bowel Dis 2011;17:1882-9.
6. de Rooy EC, Toner BB, Maunder RG, et al. Concerns of patients with inflammatory bowel disease: results from a clinical population. Am J Gastroenterol 2001;96:1816-21.
7. Vogelaar L, Van't Spijker A, van Tilburg AJ, et al. Determinants of fatigue in Crohn's disease patients. Eur J Gastroenterol Hepatol 2013;25:246-51.
8. Lix LM, Graff LA, Walker JR, et al. Longitudinal study of quality of life and psychological functioning for active, fluctuating, and inactive disease patterns in inflammatory bowel disease. Inflamm Bowel Dis 2008;14:1575-84.
9. Nijrolder I, van der Windt DA, van der Horst HE. Prognosis of fatigue and functioning in primary care: a 1-year follow-up study. Ann Fam Med 2008;6:519-27.
10. Timmer A, Preiss JC, Motschall E, et al. Psychological interventions for treatment of inflammatory bowel disease. Cochrane Database Syst Rev 2011;2:CD006913.
11. von Wietersheim J, Kessler H. Psychotherapy with chronic inflammatory bowel disease patients: a review. Inflamm Bowel Dis 2006;12:1175-84. (Pubitemid 44847475)
12. Boye B, Lundin KE, Jantschek G, et al. INSPIRE study: does stress management improve the course of inflammatory bowel disease and disease-specific quality of life in distressed patients with ulcerative colitis or Crohn's disease? A randomized controlled trial. Inflamm Bowel Dis 2011;17:1863-73.
13. Kennedy AP, Nelson E, Reeves D, et al. A randomised controlled trial to assess the effectiveness and cost of a patient orientated self management approach to chronic inflammatory bowel disease. Gut 2004;53:1639-45. (Pubitemid 39434108)
14. Garcia-Vega E, Fernandez-Rodriguez C. A stress management programme for Crohn's disease. Behav Res Ther 2004;42:367 -83.
15. Oxelmark L, Magnusson A, Lofberg R, et al. Group-based intervention program in inflammatory bowel disease patients: effects on quality of life. Inflamm Bowel Dis 2007;13:182-90. (Pubitemid 46806227)
16. Langhorst J, Anthonisen IB, Steder-Neukamm U, et al. Patterns of complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease: perceived stress is a potential indicator for CAM use. Complement Ther Med 2007;15:30-7. (Pubitemid 46359916)
17. Mussell M, Bocker U, Nagel N, et al. Reducing psychological distress in patients with inflammatory bowel disease by cognitive-behavioural treatment: exploratory study of effectiveness. Scand J Gastroenterol 2003;38:755-62. (Pubitemid 36920498)
18. Diaz Sibaja MA, Comeche Moreno MI, Mas Hesse B. [Protocolized cognitive-behavioural group therapy for inflammatory bowel disease]. Rev Esp Enferm Dig 2007;99:593-8.
19. Servaes P, Verhagen C, Bleijenberg G. Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. Eur J Cancer 2002;38:27-43. (Pubitemid 34031823)
20. Swain MG. Fatigue in chronic disease. Clin Sci (Lond) 2000;99:1-8. (Pubitemid 30479387)
21. Gielissen MF, Verhagen S, Witjes F, et al. Effects of cognitive behavior therapy in severely fatigued disease-free cancer patients compared with patients waiting for cognitive behavior therapy: a randomized controlled trial. J Clin Oncol 2006;24:4882-7. (Pubitemid 46630915)
22. van Kessel K, Moss-Morris R, Willoughby E, et al. A randomized controlled trial of cognitive behavior therapy for multiple sclerosis fatigue. Psychosom Med 2008;70:205-13. (Pubitemid 351252969)
23. Hammond A, Bryan J, Hardy A. Effects of a modular behavioural arthritis education programme: a pragmatic parallel-group randomized controlled trial. Rheumatology (Oxford) 2008;47:1712-18.
24. Hewlett S, Ambler N, Almeida C, et al. Self-management of fatigue in rheumatoid arthritis: a randomised controlled trial of group cognitive-behavioural therapy. Ann Rheum Dis 2011;70:1060-7.
25. Vogelaar L, Van't Spijker A, Vogelaar T, et al. Solution focused therapy: a promising new tool in the management of fatigue in Crohn's disease patients psychological interventions for the management of fatigue in Crohn's disease. J Crohns Colitis 2011;5:585-91.
26. D'Haens G, Ferrante M, Vermeire S, et al. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease. Inflamm Bowel Dis 2012;18:2218-24.
27. Louis E, Mary JY, Vernier-Massouille G, et al. Maintenance of remission among patients with Crohn's disease on antimetabolite therapy after infliximab therapy is stopped. Gastroenterology 2012;142:63-70 e5; quiz e31.
28. Vercoulen JH, Alberts M, Bleijenberg G. De Checklist Individual Strength (CIS). Gedragtherapie 1999;32:131-6.
29. Krupp LB, LaRocca NG, Muir-Nash J, et al. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989;46:1121-3. (Pubitemid 19246303)
30. Taylor RR, Jason LA, Torres A. Fatigue rating scales: an empirical comparison. Psychol Med 2000;30:849-56. (Pubitemid 30623970)
31. Schwartz JE, Jandorf L, Krupp LB. The measurement of fatigue: a new instrument. J Psychosom Res 1993;37:753-62. (Pubitemid 23285135)
32. Guyatt G, Mitchell A, Irvine EJ, et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989;96:804-10. (Pubitemid 19057603)
33. Irvine EJ, Feagan BG, Wong CJ. Does self-administration of a quality of life index for inflammatory bowel disease change the results? J Clin Epidemiol 1996;49:1177-85. (Pubitemid 26348616)
34. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
35. McHorney CA, Ware JE Jr, Lu JF, et al. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994;32:40-66.
36. Johnson JA, Coons SJ, Ergo A, et al. Valuation of EuroQOL (EQ-5D) health states in an adult US sample. Pharmacoeconomics 1998;13:421-33. (Pubitemid 28140701)
37. Snaith RP, Zigmond AS. The hospital anxiety and depression scale. Br Med J (Clin Res Ed) 1986;292:344.
38. Buysse DJ, Reynolds CF III, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193 -213.
39. Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976;70:439-44.
40. Winship DH, Summers RW, Singleton JW, et al. National Cooperative Crohn's Disease Study: study design and conduct of the study. Gastroenterology 1979;77:829-42. (Pubitemid 9257851)
41. Lichtiger S, Present DH, Kornbluth A, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994;330:1841-5. (Pubitemid 24188135)
42. Singer JD, Willett JB. Applied longitudinal data analysis - modeling change and event occurrence. Oxford University Press 2003.
43. Verbeke G, Molenberghs G. Linear mixed models for longitudinal data. New York: Springer 2000.
44. Cohen J. Statistical power analysis for the behavioral sciences. New York: Academic Press, 1969.
45. Bernstein CN, Singh S, Graff LA, et al. A prospective population-based study of triggers of symptomatic flares in IBD. The American journal of gastroenterology 2010;105:1994-2002.
46. Mittermaier C, Dejaco C, Waldhoer T, et al. Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom Med 2004;66:79-84. (Pubitemid 38146536)
47. Boonen A, Dagnelie PC, Feleus A, et al. The impact of inflammatory bowel disease on labor force participation: results of a population sampled case-control study. Inflamm Bowel Dis 2002;8:382-9. (Pubitemid 36411024)
48. Longobardi T, Jacobs P, Bernstein CN. Work losses related to inflammatory bowel disease in the United States: results from the National Health Interview Survey. Am J Gastroenterol 2003;98:1064-72. (Pubitemid 36733768)
49. Reinisch W, Sandborn WJ, Bala M, et al. Response and remission are associated with improved quality of life, employment and disability status, hours worked, and productivity of patients with ulcerative colitis. Inflamm Bowel Dis 2007;13:1135-40. (Pubitemid 47402598)
50. Stark R, Konig HH, Leidl R. Costs of inflammatory bowel disease in Germany. Pharmacoeconomics 2006;24:797-814. (Pubitemid 44232107)
51. Sorensen VZ, Olsen BG, Binder V. Life prospects and quality of life in patients with Crohn's disease. Gut 1987;28:382-5. (Pubitemid 17056870)
52. Hoivik ML, Moum B, Solberg IC, et al. Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study. Gut 2013;62:368-375.
53. Nurmi E, Haapamaki J, Paavilainen E, et al. The burden of inflammatory bowel disease on health care utilization and quality of life. Scand J Gastroenterol 2013;48:51-7.
54. Gunnarsson C, Chen J, Rizzo JA, et al. The Employee Absenteeism Costs of Inflammatory Bowel Disease: Evidence From US National Survey Data. J Occup Environ Med 2013;55:393-401.
55. Rocchi A, Benchimol EI, Bernstein CN, et al. Inflammatory bowel disease: a Canadian burden of illness review. Can J Gastroenterol 2012;26:811-17.
56. Deter HC, Keller W, von Wietersheim J, et al. Psychological treatment may reduce the need for healthcare in patients with Crohn's disease. Inflamm Bowel Dis 2007;13:745-52.
57. Deter HC, von Wietersheim J, Jantschek G, et al. High-utilizing Crohn's disease patients under psychosomatic therapy. Biopsychosoc Med 2008;2:18.
58. de Boer AG, Sprangers MA, Bartelsman JF, et al. Predictors of health care utilization in patients with inflammatory bowel disease: a longitudinal study. Eur J Gastroenterol Hepatol 1998;10:783-9. (Pubitemid 28493189)
59. David N, Schlenker P, Prudlo U, et al. Online counseling via e-mail for breast cancer patients on the German internet: preliminary results of a psychoeducational intervention. Psychosoc Med 2011;8:Doc05.
60. Groarke A, Curtis R, Kerin M. Cognitive-behavioural stress management enhances adjustment in women with breast cancer. Br J Health Psychol. 2013;18:623-41.
61. Jantschek G, Zeitz M, Pritsch M, et al. Effect of psychotherapy on the course of Crohn's disease. Results of the German prospective multicenter psychotherapy treatment study on Crohn's disease. German Study Group on Psychosocial Intervention in Crohn's Disease. Scand J Gastroenterol 1998;33:1289-96. (Pubitemid 29046535)
62. Herth K. Hope in older adults in community and institutional settings. Issues Ment Health Nurs 1993;14:139-56.
63. Duggleby WD, Swindle J, Peacock S, et al. A mixed methods study of hope, transitions, and quality of life in family caregivers of persons with Alzheimer's disease. BMC Geriatr 2011;11:88.
64. Gumus AB, Cam O, Malak AT. Relationships between psychosocial adjustment and hopelessness in women with breast cancer. Asian Pac J Cancer Prev 2011;12:433-8.
65. Baggs K, Spence SH. Effectiveness of booster sessions in the maintenance and enhancement of treatment gains following assertion training. J Consult Clin Psychol 1990;58:845-54.
66. Clarke GN, Rohde P, Lewinsohn PM, et al . Cognitive-behavioral treatment of adolescent depression: efficacy of acute group treatment and booster sessions. J Am Acad Child Adolesc Psychiatry 1999;38:272-9. (Pubitemid 29108739)
67. Keefer L, Doerfler B, Artz C. Optimizing management of Crohn's disease within a project management framework: Results of a pilot study. Inflamm Bowel Dis 2011.
68. Milne B, Joachim G, Niedhardt J. A stress management programme for inflammatory bowel disease patients. J Adv Nurs 1986;11:561-7.
69. Keefer L, Kiebles JL, Martinovich Z, et al. Behavioral interventions may prolong remission in patients with inflammatory bowel disease. Behav Res Ther 2011;49:145-50.